Fidelity Buys Into the Boston Scientific Corporation Comeback Story in a Big Way

Get the latest biotech news where you want it. Sign up for the free GenePool newsletter today!

Mutual fund powerhouse Fidelity discloses a 10.5% stake in Boston Scientific, making it the medical device company's largest institutional shareholder. Fidelity bought into the Boston Scientific (NYSE:BSX) comeback in a big way, revealing in a regulatory filing a nearly 10.5% stake in the medical device company. With its investment, Fidelity supplants Dodge & Cox., as Boston Scientific's largest institutional shareholder.

Help employers find you! Check out all the jobs and post your resume.
MORE ON THIS TOPIC